N

Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538

Watchlist Manager
Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538
Watchlist
Price: 13.09 CNY -5.56% Market Closed
Market Cap: 2.8B CNY
Have any thoughts about
Ningbo Menovo Pharmaceutical Co Ltd?
Write Note

Gross Margin
Ningbo Menovo Pharmaceutical Co Ltd

29.2%
Current
35%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.2%
=
Gross Profit
362.3m
/
Revenue
1.2B

Gross Margin Across Competitors

Country CN
Market Cap 2.9B CNY
Gross Margin
29%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 710.5B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.5B USD
Gross Margin
69%
Country US
Market Cap 251.1B USD
Gross Margin
77%
Country CH
Market Cap 202.7B CHF
Gross Margin
73%
Country CH
Market Cap 183.3B CHF
Gross Margin
75%
Country UK
Market Cap 162.4B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%
No Stocks Found

Ningbo Menovo Pharmaceutical Co Ltd
Glance View

Market Cap
2.9B CNY
Industry
Pharmaceuticals

Ningbo Menovo Pharmaceutical Co., Ltd. engages in the research, development, testing, production, and sale of pharmaceutical products. The company is headquartered in Ningbo, Zhejiang and currently employs 2,473 full-time employees. The company went IPO on 2017-04-07. The Company’s products contain gastropathic medicine and cardiovascular medicine, which include anti-hypertension medicine, anti-hyperlipidemia medicine and anti-thrombus medicine. The firm distributes its products to both domestic and overseas markets.

Intrinsic Value
12.45 CNY
Overvaluation 5%
Intrinsic Value
Price
N

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.2%
=
Gross Profit
362.3m
/
Revenue
1.2B
What is the Gross Margin of Ningbo Menovo Pharmaceutical Co Ltd?

Based on Ningbo Menovo Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 29.2%.